The recent success of glucagon-like peptide-1 (GLP-1) medications in supporting rapid weight loss has garnered substantial popular attention, particularly as new studies identify reductions in cardiovascular risk and other major health issues associated with obesity [47]. The gene discussed is GCG; the disease is Obesity.